Lewis Cantley

인용

	전체	2020년 이후
서지정보	250432	64721
h-index	232	111
i10-index	655	441

15000

7500

3750

11250

1986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025676 636 671 780 950 1147 1532 1723 2179 2344 2805 3109 4064 4171 4229 4120 4004 4178 4649 4769 5151 5269 6175 6472 7433 8275 9812 10640 11080 11755 11510 11395 11481 11911 12752 14108 12939 11709 11535 1661

공개 액세스

모두 보기

자료 292개

자료 6개

공개

비공개

재정 지원 요구사항 기준

공동 저자

John AsaraAssociate Professor Medicine, Harvard Medical School; Director, Beth Israel Deaconess Medical Centerbidmc.harvard.edu의 이메일 확인됨
Costas LyssiotisProfessor of Physiology, University of Michiganlyssiotis.com의 이메일 확인됨
Ji LuoNational Cancer Institutenih.gov의 이메일 확인됨
David FrumanProfessor of Molecular Biology & Biochemistry, UC Irvineuci.edu의 이메일 확인됨
John BlenisProfessor of Pharmacology, Weill Cornell Medicinemed.cornell.edu의 이메일 확인됨
Alex Tokerbidmc.harvard.edu의 이메일 확인됨
Jason LocasaleDuke Universityalum.mit.edu의 이메일 확인됨
Brendan D. ManningHarvard Universityhsph.harvard.edu의 이메일 확인됨
Lucia Rameh PlantVanderbilt Universityvanderbilt.edu의 이메일 확인됨
C. Ronald KahnJoslin Diabetes Center and Harvard Medical Schooljoslin.harvard.edu의 이메일 확인됨
Reuben ShawThe Salk Institute of Biological Studiessalk.edu의 이메일 확인됨
Pier Paolo PandolfiDirector, Cancer Center and Cancer Research Institute, Beth Israel Deaconess Medical Centerbidmc.harvard.edu의 이메일 확인됨
Ronald A. DePinhoMD Andersonmdanderson.org의 이메일 확인됨
David R. KaplanHospital for Sick Childrensickkids.ca의 이메일 확인됨
Steven ShoelsonHarvard Medical Schooljoslin.harvard.edu의 이메일 확인됨
Gerburg WulfAssociate Professor in Medicine, Harvard Medical Schoolbidmc.harvard.edu의 이메일 확인됨
Kurt AugerGSKgsk.com의 이메일 확인됨
Pasi JanneDana Farber Cancer Institutedfci.harvard.edu의 이메일 확인됨
Marcus D GoncalvesWeill Cornell New York Presbyterian Hospitalmed.cornell.edu의 이메일 확인됨
Malcolm WhitmanHarvardhms.harvard.edu의 이메일 확인됨

팔로우

Lewis Cantley

Dana Farber Cancer Center and Harvard Medical School

med.cornell.edu의 이메일 확인됨

cancer metabolism signal transduction PI 3-Kinase Protein kinases


제목 서지정보순 정렬 연도순 정렬 제목순 정렬	인용 인용	연도
Understanding the Warburg effect: the metabolic requirements of cell proliferation MG Vander Heiden, LC Cantley, CB Thompson science 324 (5930), 1029-1033, 2009	17533	2009
AKT/PKB signaling: navigating downstream BD Manning, LC Cantley Cell 129 (7), 1261-1274, 2007	7573	2007
The phosphoinositide 3-kinase pathway LC Cantley Science 296 (5573), 1655-1657, 2002	7447	2002
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling JA Engelman, K Zejnullahu, T Mitsudomi, Y Song, C Hyland, JO Park, ... science 316 (5827), 1039-1043, 2007	5558	2007
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate L Dang, DW White, S Gross, BD Bennett, MA Bittinger, EM Driggers, ... Nature 462 (7274), 739-744, 2009	4866	2009
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism JA Engelman, J Luo, LC Cantley Nature Reviews Genetics 7 (8), 606-619, 2006	4084	2006
Oncogenes and signal transduction LC Cantley, KR Auger, C Carpenter, B Duckworth, A Graziani, R Kapeller, ... Cell 64 (2), 281-302, 1991	3598	1991
SH2 domains recognize specific phosphopeptide sequences S Zhou, SE Shoelson, M Chaudhuri, G Gish, T Pawson, WG Haser, F King, ... Cell 72 (5), 767-778, 1993	3591	1993
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth HR Christofk, MG Vander Heiden, MH Harris, A Ramanathan, ... Nature 452 (7184), 230-233, 2008	3284	2008
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis GM DeNicola, FA Karreth, TJ Humpton, A Gopinathan, C Wei, K Frese, ... Nature 475 (7354), 106-109, 2011	2950*	2011
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway LC Cantley, BG Neel Proceedings of the National Academy of Sciences 96 (8), 4240-4245, 1999	2774	1999
Ras, PI (3) K and mTOR signalling controls tumour cell growth RJ Shaw, LC Cantley Nature 441 (7092), 424-430, 2006	2672	2006
The PI3K pathway in human disease DA Fruman, H Chiu, BD Hopkins, S Bagrodia, LC Cantley, RT Abraham Cell 170 (4), 605-635, 2017	2460	2017
PI3K pathway alterations in cancer: variations on a theme TL Yuan, LC Cantley Oncogene 27 (41), 5497-5510, 2008	2449	2008
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin RJ Shaw, KA Lamia, D Vasquez, SH Koo, N Bardeesy, RA DePinho, ... Science 310 (5754), 1642-1646, 2005	2422	2005
PI3K: downstream AKTion blocks apoptosis TF Franke, DR Kaplan, LC Cantley Cell 88 (4), 435-437, 1997	2215	1997
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress RJ Shaw, M Kosmatka, N Bardeesy, RL Hurley, LA Witters, RA DePinho, ... Proceedings of the National Academy of Sciences 101 (10), 3329-3335, 2004	2190	2004
Phosphoinositide kinases DA Fruman, RE Meyers, LC Cantley Annual review of biochemistry 67 (1), 481-507, 1998	2155	1998
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism H Ying, AC Kimmelman, CA Lyssiotis, S Hua, GC Chu, ... Cell 149 (3), 656-670, 2012	2140	2012
Bidirectional transport of amino acids regulates mTOR and autophagy P Nicklin, P Bergman, B Zhang, E Triantafellow, H Wang, B Nyfeler, ... Cell 136 (3), 521-534, 2009	2046	2009

현재 시스템이 작동되지 않습니다. 나중에 다시 시도해 주세요.

학술자료 1–20

연간 인용횟수

중복된 서지정보

병합된 서지정보

공동 저자 추가공동 저자

팔로우

인용

공동 저자